ROR1 and breast neoplasm: Across all breast tumor samples in the TCGA, ROR1 did not significantly predict survival with a hazard ratio of 1.33 (p = 0.14), but confirmed the highest ROR1 expression in BLBC compared to other molecular subtypes (n = 821 with molecular subtype designations, Figure 1b).